Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
25.26
+0.34 (1.36%)
Mar 6, 2026, 4:00 PM EST
SHA:688739 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,405 | 10,594 | 10,612 | 13,539 | 12,668 | 31,704 | Upgrade
|
| Market Cap Growth | -3.67% | -0.17% | -21.62% | 6.87% | -60.04% | - | Upgrade
|
| Enterprise Value | 5,347 | 5,536 | 5,273 | 7,974 | 7,019 | 29,988 | Upgrade
|
| Last Close Price | 25.30 | 25.76 | 25.01 | 30.57 | 27.77 | 68.12 | Upgrade
|
| PE Ratio | 76.67 | 76.98 | 30.96 | 29.06 | 17.74 | 35.52 | Upgrade
|
| Forward PE | - | 23.69 | 23.60 | 18.60 | - | - | Upgrade
|
| PS Ratio | 7.48 | 7.62 | 6.33 | 7.74 | 6.98 | 15.18 | Upgrade
|
| PB Ratio | 1.11 | 1.13 | 1.11 | 1.41 | 1.31 | 3.39 | Upgrade
|
| P/TBV Ratio | 1.13 | 1.15 | 1.13 | 1.44 | 1.34 | 3.44 | Upgrade
|
| P/FCF Ratio | - | - | 76.63 | 108.30 | 363.13 | - | Upgrade
|
| P/OCF Ratio | - | - | 21.18 | 20.00 | 23.18 | 62.61 | Upgrade
|
| EV/Sales Ratio | 3.85 | 3.98 | 3.15 | 4.56 | 3.87 | 14.36 | Upgrade
|
| EV/EBITDA Ratio | 15.61 | 16.16 | 9.59 | 12.76 | 8.24 | 27.24 | Upgrade
|
| EV/EBIT Ratio | 30.13 | 31.19 | 13.71 | 15.80 | 9.55 | 30.29 | Upgrade
|
| EV/FCF Ratio | - | - | 38.08 | 63.79 | 201.20 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.11 | 0.16 | 0.63 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.54 | -0.54 | -0.57 | -0.59 | -0.63 | -0.68 | Upgrade
|
| Net Debt / EBITDA Ratio | -14.77 | -14.77 | -9.98 | -9.09 | -7.12 | -5.80 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -39.61 | -45.45 | -173.88 | 3244.02 | Upgrade
|
| Asset Turnover | - | - | 0.17 | 0.17 | 0.18 | 0.29 | Upgrade
|
| Inventory Turnover | - | - | 0.72 | 0.76 | 0.56 | 0.66 | Upgrade
|
| Quick Ratio | - | - | 16.73 | 19.05 | 26.38 | 25.52 | Upgrade
|
| Current Ratio | - | - | 18.01 | 20.32 | 28.23 | 26.98 | Upgrade
|
| Return on Equity (ROE) | 1.45% | 1.45% | 3.58% | 4.84% | 7.51% | 13.25% | Upgrade
|
| Return on Assets (ROA) | - | - | 2.39% | 3.13% | 4.63% | 8.67% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.21% | 3.30% | 8.19% | 10.88% | 19.14% | 34.78% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 4.00% | 5.20% | 7.50% | 10.40% | Upgrade
|
| Earnings Yield | 1.32% | 1.30% | 3.23% | 3.44% | 5.64% | 2.81% | Upgrade
|
| FCF Yield | - | - | 1.31% | 0.92% | 0.27% | -0.01% | Upgrade
|
| Dividend Yield | 3.17% | - | 3.20% | 2.62% | 3.60% | 1.47% | Upgrade
|
| Payout Ratio | - | - | 96.08% | 89.35% | 58.30% | - | Upgrade
|
| Buyback Yield / Dilution | -0.96% | -0.96% | 0.71% | 0.37% | -9.48% | -1.77% | Upgrade
|
| Total Shareholder Return | 2.20% | -0.96% | 3.91% | 2.99% | -5.88% | -0.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.